Memorial Sloan Kettering Nassau (Consent Only) — Uniondale, New York

Public research footprint of Memorial Sloan Kettering Nassau (Consent Only), compiled from the ClinicalTrials.gov public registry.

547

Registered studies

415

Active

199

Recruiting now

106

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia Arising From Previous… · Resectable Pancreatic Acinar Cell Carcinoma · Stage IVB Prostate Cancer AJCC v8 · Breast Cancer

Recently updated registry entries

NCT04269902 — Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or… (Recruiting)
NCT06168812 — A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer (Active Not Recruiting)
NCT07061977 — Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Memorial Sloan Kettering Nassau (Consent Only)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.